Hospital de la Santa Creu i Sant Pau-ko ikertzaileekin lankidetzan egindako argitalpenak (13)

2019

  1. Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 3, pp. 355-364

2016

  1. Genome-Wide Pathway Analysis Identifies Genetic Pathways Associated with Psoriasis

    Journal of Investigative Dermatology, Vol. 136, Núm. 3, pp. 593-602

  2. Urine metabolome profiling of immune-mediated inflammatory diseases

    BMC Medicine, Vol. 14, Núm. 1

2015

  1. A deletion at adamts9-magi1 locus is associated with psoriatic arthritis risk

    Annals of the Rheumatic Diseases, Vol. 74, Núm. 10, pp. 1875-1881

  2. Association of the PDE3A-SLCO1C1 locus with the response to anti-TNF agents in psoriasis

    Pharmacogenomics Journal, Vol. 15, Núm. 4, pp. 322-325

  3. Immune-mediated inflammatory diseases and other comorbidities in patients with psoriasis: Baseline characteristics of patients in the aquiles study

    Actas Dermo-Sifiliograficas, Vol. 106, Núm. 1, pp. 35-43

2014

  1. Enfermedades inflamatorias mediadas por inmunidad en pacientes con enfermedad inflamatoria intestinal. Datos basales del estudio Aquiles

    Gastroenterologia y Hepatologia, Vol. 37, Núm. 9, pp. 495-502

2013

  1. Guidelines for the use of acitretin in psoriasis

    Actas Dermo-Sifiliograficas

  2. Mental health self-assessment in patients with moderate to severe psoriasis: An observational, multicenter study of 1164 patients in Spain (The VACAP study)

    Actas Dermo-Sifiliograficas, Vol. 104, Núm. 10, pp. 897-903

2012

  1. Risk variants for psoriasis vulgaris in a large case-control collection and association with clinical subphenotypes

    Human Molecular Genetics, Vol. 21, Núm. 20, pp. 4549-4557

2011

  1. Diseño y validación de un cuestionario para medir la satisfacción con el tratamiento del paciente con psoriasis moderada y grave: Estudio NEODERMA

    Actas Dermo-Sifiliograficas, Vol. 102, Núm. 1, pp. 28-38

2010

  1. Guidelines on the use of methotrexate in psoriasis

    Actas Dermo-Sifiliograficas, Vol. 101, Núm. 7, pp. 600-613

2009

  1. Consensus document on the evaluation and treatment of moderate-to-severe psoriasis. Spanish Psoriasis Group* of the Spanish Academy of Dermatology and Venereology

    Actas Dermo-Sifiliograficas, Vol. 100, Núm. 4, pp. 277-286